Budisa N, Steipe B, Demange P, Eckerskorn C, Kellermann J, Huber R
Max-Planck Institute for Biochemistry, Martinsried, Germany.
Eur J Biochem. 1995 Jun 1;230(2):788-96. doi: 10.1111/j.1432-1033.1995.tb20622.x.
We have utilized a T7 polymerase/promoter system for the high-level incorporation of methionine analogs with suitable labels for structural research (X-ray and NMR studies) on recombinant annexin V produced in Escherichia coli. Here, we describe, to our knowledge, the first biosynthetic high-level substitution of methionine by 2-aminohexanoic acid (norleucine), ethionine and telluromethionine in a protein. The replacement has been confirmed by electrospray mass spectroscopy, amino acid analysis and X-ray structural analysis. Conditions for expression were optimized concerning the frequency of appearance of revertants, high-level replacement and maximal protein yield. For the incorporation of norleucine and ethionine, E. coli B834 (DE3)(hsd metB), which is auxotrophic for methionine, was grown under methionine-limited conditions with an excess of the analog in the culture medium, and the expression of protein under the control of the T7 promoter was induced after the methionine supply had been exhausted. The factor limiting the high-level incorporation of telluromethionine into protein is its sensitivity towards oxidation. To overcome this problem, bacteria were grown with a limited amount of methionine, harvested after its exhaustion and resuspended in fresh media without methionine; telluromethionine was added and protein synthesis induced. Under these conditions, significant amounts of protein can be expressed before telluromethionine has been completely degraded (within hours). Biosynthetic incorporation of heavy atoms such as tellurium into recombinant proteins can accelerate the process of obtaining heavy-atom derivatives suitable for X-ray structural analysis, supplementing the traditional trial-and-error preparation of heavy-atom derivatives for the method of multiple isomorphous replacement. Furthermore, the successful high-level incorporation of amino acid analogs can provide single-atom mutations for the detailed study of the structure and function of proteins.
我们利用T7聚合酶/启动子系统,将带有合适标记的甲硫氨酸类似物高水平掺入,用于对在大肠杆菌中产生的重组膜联蛋白V进行结构研究(X射线和核磁共振研究)。在此,据我们所知,我们描述了蛋白质中甲硫氨酸首次被2-氨基己酸(正亮氨酸)、乙硫氨酸和碲代甲硫氨酸进行生物合成的高水平取代。这种取代已通过电喷雾质谱、氨基酸分析和X射线结构分析得到证实。针对回复突变体出现的频率、高水平取代和最大蛋白产量,对表达条件进行了优化。为了掺入正亮氨酸和乙硫氨酸,对甲硫氨酸营养缺陷型的大肠杆菌B834(DE3)(hsd metB)在甲硫氨酸受限的条件下,于培养基中加入过量的类似物进行培养,在甲硫氨酸供应耗尽后,诱导T7启动子控制下的蛋白表达。限制碲代甲硫氨酸高水平掺入蛋白质的因素是其对氧化的敏感性。为克服这个问题,细菌在有限量的甲硫氨酸条件下生长,在甲硫氨酸耗尽后收获并重悬于不含甲硫氨酸的新鲜培养基中;加入碲代甲硫氨酸并诱导蛋白合成。在这些条件下,在碲代甲硫氨酸完全降解(数小时内)之前,可以表达大量的蛋白质。将碲等重原子生物合成掺入重组蛋白可以加速获得适用于X射线结构分析的重原子衍生物的过程,补充了用于多重同晶置换法的重原子衍生物传统的试错制备方法。此外,氨基酸类似物的成功高水平掺入可为蛋白质的结构和功能的详细研究提供单原子突变。